Name | 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol |
---|---|
Synonyms |
hms3269l05
phtpp |
Description | PHTPP is a selective ERβ antagonist. |
---|---|
Related Catalog | |
Target |
ERβ[1] |
In Vitro | PHTPP is a selective ERβ antagonist. PHTPP reduces FSH-mediated cAMP production by 80% (p<0.01) while it has no effect on basal cAMP[1]. PHTPP (10-6 M) inhibits E2-stimulated ERβ activity, but does not suppress E2-stimulated ERα activity. A high dose of PHTPP (10-6 M) slightly increases class 1 Igf1 mRNA expression, and facilitates the DPN-induced increase in class 1 Igf1 mRNA expression[2]. |
Cell Assay | Cells are plated at a density of 3 to 4×105 in 1 mL of medium per well in a 24-well plate for cell viability and cAMP analysis. Cells are cultured in Dulbecco’s Modified Eagle Medium with PHTPP (1 μM), or ethanol (0.1%) as the vehicle. The incubator is set to an atmosphere of 5% CO2 in air at 37°C, and cultures are allowed to acclimate for at least 24 h. The culture medium is then aspirated and replaced with serum-free DMEM/F12 containing 0.1 μM androstenedione. The cells are collected for intracellular cAMP and to test cell viability[1]. |
References |
Density | 1.48g/cm3 |
---|---|
Molecular Formula | C20H11F6N3O |
Molecular Weight | 423.31100 |
Exact Mass | 423.08100 |
PSA | 50.42000 |
LogP | 5.80650 |
Index of Refraction | 1.584 |
Storage condition | -20℃ |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 |
Precautionary Statements | P301 + P310 + P330 |
RIDADR | UN 2811 6.1 / PGIII |